Sharemaestro Newsreel

ALC Maintained by Mizuho -- Price Target Raised to $85.00

Mizuho has maintained an "Outperform" rating for Alcon (ALC) and raised its price target from $80.00 to $85.00, reflecting optimism about the company's growth potential. GuruFocus assesses ALC as 15.0% undervalued with a GF Value™ of $88.60 against its current price of $75.35, and …

UBS Adjusts Becton Dickinson and Co. PT to $205 From $190, Maintains Buy Rating

UBS has increased its price target for Becton Dickinson and Co. (BDX) to $205 from $190, while reiterating a "Buy" rating on the stock. This adjustment reflects a positive outlook from the analyst firm on the medical technology company. The article also lists recent …

Intuitive Surgical (ISRG) Stock Has Plunged 33% in 2026. Here's Why One Fund Manager Remains Bullish -- and Why I Do, Too.

Key Points The robotic surgery specialist has over 12,000 installed systems globally. Right now, it's facing some headwinds, but it also has a lot going for it. The Baron Health Care Fund sees Intuitive Surgical as full of promise.10 stocks we like better than …

Alcon’s New-Product Wave Carries Q2 As It Walks Away From Accommodating IOL Bet

Alcon's new product launches are credited for its strong Q2 performance. The company expects a $60 million refund from the US government, two-thirds of which will be reinvested. This comes as Alcon pivots away from accommodating intraocular lenses (IOLs) and focuses on other areas …

Intuitive Surgical: Oppenheimer now bullish, sees competition being "crowded out"

Investing.com -- Oppenheimer upgraded Intuitive Surgical to Outperform from Perform with a $500 price target in a note on Wednesday, arguing the company's strategy of "Crowding Out Competitors" is strategically smart. Analyst Suraj Kalia said the change reflects "a more nuanced risk-reward assessment at …

Femasys' Non-Surgical Permanent Birth Control Gains Global Patents

Femasys (NASDAQ: FEMY) announced the issuance of new patents in the United States and several international markets for the blended polymer component of its non-surgical permanent birth control technology, FemBloc. These patents enhance FemBloc's intellectual property protection, complementing existing patents for its delivery system. …

If You Invested $1000 in Intuitive Surgical, Inc. 10 Years Ago, This Is How Much You'd Have Now

This article examines the hypothetical return on a $1000 investment in Intuitive Surgical, Inc. (ISRG) made ten years ago. It details the company's business, including its da Vinci surgical system and Ion endoluminal system, and highlights its 2025 financial results. The article concludes that …

Here Are Wednesday’s Top Wall Street Analyst Research Calls: The Gap, Genmab, Hilton Worldwide, Intuitive Surgical, Mariott International, Merck, Novo Nordisk, Okta, and More

Pre-Market Stock Futures: Futures are trading modestly higher as we have arrived at the day everyone on Wall Street has circled on their calendars. The July consumer price index will be released at 8:30 AM EDT, and the producer price index will be released …

Intuitive Surgical upgraded at Oppenheimer on robotic surgery market growth

Oppenheimer has upgraded Intuitive Surgical (ISRG) to outperform, citing the company's strong position to benefit from the growing robotic surgery market. Despite increasing competition from companies like Johnson & Johnson (JNJ), Oppenheimer believes Intuitive Surgical will maintain its market dominance. This upgrade reflects confidence …

BD Accelerates Advanced Tissue Regeneration Strategy with Landmark PREVENT Trial

Enrollment completed in the first large-scale randomized study evaluating Phasix™ Mesh for incisional hernia prevention, a significant unmet need following abdominal surgery FRANKLIN LAKES, N.J., Aug. 12, 2026 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today …

Microbot Medical Q2 revenue jumps 100% QoQ

Microbot Medical Inc. announced a 100% quarter-over-quarter revenue and customer growth for Q2 2026, driven by the successful Full Market Release of its LIBERTY System. The company expanded its market presence in the U.S., secured a federal healthcare agreement, and achieved international marketing clearance …

ResMed (RMD) Stock May Be 31% Undervalued After Soft FY27 Outlook

Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge. ResMed stock has lagged over the past year, yet both the Discounted Cash Flow (DCF) intrinsic value estimate and the market multiples currently point to the shares …

Mizuho raises Alcon stock price target to $85 on new products

Mizuho has increased its price target for Alcon Inc. (NYSE:ALC) shares from $80 to $85, maintaining an Outperform rating, due to anticipated new product growth from Unity VCS and Tryptyr in Q2 2026. Despite headwinds in certain divisions like Implantables, Panoptix Pro share gains …

Wasatch Advisors LP Buys 346,720 Shares of Repligen Corporation $RGEN

Wasatch Advisors LP has significantly increased its stake in Repligen Corporation (NASDAQ:RGEN) by 27.9%, purchasing an additional 346,720 shares, bringing its total holdings to 1.59 million shares valued at approximately $217 million. This makes Repligen the 19th largest holding for Wasatch Advisors, representing 1.4% …

Pacer Advisors Inc. Has $266,000 Stake in DENTSPLY SIRONA Inc. $XRAY

Pacer Advisors Inc. significantly reduced its stake in DENTSPLY SIRONA Inc. by 90.5% in the first quarter, now holding 22,973 shares valued at $266,000. Institutional investors collectively own 95.7% of the company, while analyst ratings are mixed with an average "Hold" and target price …

Oppenheimer Sees $500 for Intuitive Surgical as Rivals Stall

Oppenheimer upgraded Intuitive Surgical (ISRG) to Outperform with a $500 price target, citing issues with competitors Johnson & Johnson's Ottava system and Medtronic's Hugo. The firm believes Intuitive's da Vinci franchise will face no credible domestic challenger in the near term and that its …

Align Technology Prevails in China Patent Infringement Action

Align Technology (ALGN) disclosed late Tuesday that the Jinan Intermediate People's Court in China issued a judgment in its favor, in a patent infringement action against Angelalign Technology's operating subsidiaries in China.The company provides an orthodontic treatment system Silver Upgrade to read this MT …

Annex Advisory Services LLC Raises Stock Position in Intuitive Surgical, Inc. $ISRG

Annex Advisory Services LLC has increased its stake in Intuitive Surgical (NASDAQ:ISRG) by 37.4% in the second quarter, bringing its total holdings to 90,943 shares valued at $36.2 million. This comes as Intuitive Surgical reported strong Q2 results, with revenue up 18.4% and EPS …

Assenagon Asset Management S.A. Invests $6.35 Million in Anteris Technologies Global Corp. $AVR

Assenagon Asset Management S.A. has acquired a new stake of 644,668 shares, worth approximately $6.35 million, in Anteris Technologies Global Corp. (NASDAQ:AVR). This investment gives Assenagon Asset Management a 0.66% ownership in the company, while major shareholder L1 Capital recently sold 558,633 shares for …

Cardinal Capital Management Inc. Has $27 Million Position in Becton, Dickinson and Company $BDX

Cardinal Capital Management Inc. increased its stake in Becton, Dickinson and Company (NYSE:BDX) by 6.6% in the second quarter, bringing its total holdings to 178,421 shares valued at $27 million. This article details significant movements by other institutional investors in BDX, lists recent analyst …

Assenagon Asset Management S.A. Buys New Shares in Repligen Corporation $RGEN

Assenagon Asset Management S.A. has acquired 70,995 new shares of Repligen Corporation (NASDAQ:RGEN) valued at approximately $9.7 million, making them a 0.13% owner of the biotechnology company. Repligen recently surpassed its quarterly earnings and revenue expectations, reporting $0.54 EPS against a $0.45 consensus, with …

Assenagon Asset Management S.A. Sells 70,521 Shares of Merit Medical Systems, Inc. $MMSI

Assenagon Asset Management S.A. significantly reduced its stake in Merit Medical Systems (NASDAQ:MMSI) by selling 70,521 shares, lowering its holdings by 34.2%. Despite this reduction, institutional investors collectively own 99.66% of the company, which recently reported strong quarterly earnings exceeding expectations and issued positive …

Key facts: Alcon AG (ALC) Q2 sales +7%; Q3 gross margin to rise

Alcon AG (ALC) reported a 7% increase in Q2 sales, driven by UNITY equipment, PanOptix Pro IOL, contact lenses, and ocular health growth, leading to higher core margins and EPS. The company reiterated its 2026 sales growth guidance of 5–7% and EPS growth of …

Bank of America Corp DE Buys 27,004 Shares of Teleflex Incorporated $TFX

Bank of America Corp DE increased its stake in Teleflex Incorporated by 6.4% in the first quarter, acquiring an additional 27,004 shares, bringing its total holdings to 445,958 shares valued at $53.3 million. Institutional investors collectively own 95.62% of Teleflex. The company exceeded its …

Becton Dickinson (BDX) Is Up 6.6% After Strong Q3 And Higher 2026 Outlook Has The Bull Case Changed?

Becton Dickinson (BDX) reported strong third-quarter fiscal 2026 results with increased sales, although net income fell year-over-year. The company raised its full-year 2026 guidance, expecting low single-digit GAAP revenue growth, driven by a more focused medical technology portfolio and new drug-delivery collaborations. Despite the …

Stevanato Group S.p.A. (NYSE:STVN) Receives Consensus Recommendation of "Buy" from Brokerages

Stevanato Group S.p.A. (NYSE:STVN) has received a consensus "Buy" recommendation from six analysts, with two holding, two buying, and two strong buying. Recent analyst coverage includes an "outperform" rating from Wolfe Research with a $21 price target and an upgrade to "strong-buy" from TD …

The 5 Most Interesting Analyst Questions From ResMed’s Q2 Earnings Call

Kestra Medical CFO Vaseem Mahboob sells $680k in shares

Kestra Medical CFO Vaseem Mahboob sold 26,287 shares of the company for over $680,000, executed via a Rule 10b5-1 trading plan. These sales occurred as the stock neared its 52-week high after an 85% return. Despite missing earnings expectations, Kestra Medical reported a significant …

Merit Medical Systems Stock Climbs 25% On A 13-Day Winning Streak

Merit Medical Systems (MMSI) stock has surged 25% over 13 consecutive trading days, adding $1.1 billion to its market value and bringing its total valuation to $5.4 billion. This impressive streak significantly outperforms the S&P 500's 4.3% gain over the same period, suggesting company-specific …

Intuitive surgical director Amy Ladd sells $179,903 in company stock

Amy L. Ladd, a director at Intuitive Surgical Inc. (NASDAQ:ISRG), recently sold shares totaling $179,903 in August 2026 under a pre-arranged trading plan. Following these transactions, Ms. Ladd directly holds 179 shares. This news follows Intuitive Surgical's strong second-quarter results but also highlights mixed …

ICU Medical Inc (ICUI) Insider Sell: Christian Voigtlander Disposes of 8,929 Shares

Christian Voigtlander, an insider at ICU Medical Inc (ICUI), recently sold 8,929 shares for approximately $1.63 million, reducing his direct ownership to 37,377 shares. This sale contributes to a trend of more insider selling than buying at ICUI over the past year (8 sells …

Intuitive Surgical (ISRG) Director Amy Ladd Sells 472 Shares

Intuitive Surgical (ISRG) Director Amy Ladd sold 472 shares on August 11, 2026, totaling approximately $179,903, reducing her stake by over 72%. This sale is part of a larger trend of insider selling at the company, with 41 insider sells and no buys over …

Why Merit Medical Systems (MMSI) Is Up 14.4% After Raising 2026 Revenue Outlook And Margins

Merit Medical Systems (MMSI) saw its stock rise by 14.4% after reporting strong Q2 2026 results and raising its full-year 2026 revenue outlook to US$1.631 billion–US$1.643 billion. This positive revision is attributed to better-than-expected first-half performance, recent acquisitions, and efficiency gains. While the raised …

Alcon Q2 Sales Rise on Strength in Vision Care, Surgical Segments

Alcon (SIX/NYSE:ALC) reported strong financial results for Q2 2026, with net sales reaching $2.8 billion, an 8 percent increase year-over-year. Both its Vision Care and Surgical segments contributed to this growth, driven by product innovation and strategic collaborations. The company also updated its full-year …

1 Unpopular Stock That Deserves Some Love and 2 We Avoid

1 Unpopular Stock That Deserves Some Love and 2 We Avoid Wall Street's bearish price targets for the stocks in this article signal serious concerns. Such forecasts are uncommon in an industry where maintaining cordial corporate relationships often trumps delivering the hard truth. Whatever …

Femasys COO John Canning buys $14,000 in FEMY stock By Investing.com

John Canning, COO of Femasys Inc. (NASDAQ: FEMY), recently purchased 4,375 shares of company stock for $14,000 at $3.20 per share, along with two types of warrants. This transaction occurred while FEMY stock trades near its 52-week low, and InvestingPro analysis suggests the stock …